Treatment

Empagliflozin clinical trials

Active studies that list Empagliflozin as an intervention or treatment.

3active studies

2recruiting now

2countries represented

1largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 1

Overweight Subject, Healthy SubjectsCondition

Metformin, EmpagliflozinTreatment

China1 locations

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Sponsor

Updated 2026-01-09 · NCT07331389See eligibility →

Recruiting nowPhase 2

Obesity, Vascular HealthCondition

Empagliflozin, PlaceboTreatment

United States1 locations

VA Office of Research and DevelopmentSponsor

Updated 2025-11-14 · NCT06745063See eligibility →

Active, not recruitingPhase 2, Phase 3

Cystic Fibrosis-related Diabetes, Cystic FibrosisCondition

Empagliflozin, Placebo ControlTreatment

United States1 locations

University of MinnesotaSponsor

Updated 2026-01-20 · NCT06149793See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.